Furthermore, it was found that elevated levels of YKL-39 in the tumor mass after the neoadjuvant chemotherapy (NAC) have a positive correlation not only with poor response to NAC but also with the increased risk of distant metastasis [36]. Here, CHI3L2 is linked to neoplasm.